BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28

• Scythian Biosciences Announces Closing of $28.7M Financing With Aphria as Lead Investor

  A total of 772,943 units of the Company were sold at a price of $18.60 per Unit for gross proceeds of C$14,376,740.

  February 13, 2018

   · 

  5 min read
• ABiL Develops Ultrafast Genomic Algorithm, Exceeds $2M in Revenue

  This increased speed will bring improvements in the diagnosis of cancer, genetic diseases, and antibiotic resistant infections, stimulating the development of genomic approaches to healthcare.

  February 13, 2018

   · 

  2 min read
• Genetown

  SeraCare Announces Industry’s First CNV-Specific Reference Material for Gene Amplifications in Breast, Lung, and Brain Cancer

  These expert-designed products are built with innovative biosynthetic technology that is easily scalable to incorporate new CNVs over time.

  February 13, 2018

   · 

  4 min read
• PositiveID’s Thermomedics Delivers First 500 Caregiver Bluetooth Thermometers to Global Healthcare Company

  New version of Caregiver is the first FDA cleared non-contact, infrared thermometer intended for professional use that utilizes Bluetooth technology to connect wirelessly to patient monitoring stations and electronic health records systems.

  February 13, 2018

   · 

  4 min read
• Business

  Spark Therapeutics to Host Conference Call on Tuesday, Feb. 20 at 8:30 a.m. ET to Discuss 2017 Results and Recent Business Highlights

  The call can be accessed by dialing (855) 851-4526 (domestic) or (720) 634-2901 (international), and entering passcode 9596288.

  February 13, 2018

   · 

  1 min read
• Annual General Meeting in ALK-Abelló A/S on 12 March 2018

  The agenda of the meeting including the complete proposals from the Board of Directors to the AGM is attached.

  February 13, 2018

   · 

  1 min read
• Conversion of FIT Biotech Oy’s Convertible Capital Notes Into Shares - Feb. 13, 2018

  The Board authorization is based on the Extraordinary General Meeting December 14, 2017.

  February 13, 2018

   · 

  1 min read
• Median Technologies Announces Results of Deep Learning Study for Enhanced Prostate Segmentation - Helping to Advance Precision Medicine

  Study results will be presented at the SPIE Medical Imaging conference in Houston, TX, USA on February 14.

  February 13, 2018

   · 

  3 min read
• Drug Development

  Shire Provides Regulatory Progress Update for Key Pipeline Programs Targeting Rare Disease

  Shire is preparing to conduct Phase 3 trials investigating SHP647 for the treatment of moderately to severely active Crohn’s disease in adults

  February 13, 2018

   · 

  10 min read
• Business

  Pilot Chemical Names Glynn Goertzen VP of Corporate Development

  Pilot Chemical Company announced that Glynn Goertzen, president of Pilot Chemical subsidiary Liquid Minerals Group Ltd., also has been named vice president of corporate development for the parent company.

  February 13, 2018

   · 

  3 min read